- Home
- ADAMM vs FBIOP Comparison
ADAMM vs FBIOP Comparison
Compare ADAMM & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
ADAMM
Adamas Trust Inc. 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAMM | FBIOP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 221 | 78 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ADAMM | FBIOP |
|---|---|---|
| Price | $25.26 | $20.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.8K | ★ 40.1K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.78 | $6.27 |
| 52 Week High | $25.62 | $21.23 |
Technical Indicators
Market Signals| Indicator | ADAMM | FBIOP |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 76.78 |
| Support Level | $25.20 | $12.71 |
| Resistance Level | $25.58 | N/A |
| Average True Range (ATR) | 0.15 | 0.72 |
| MACD | -0.03 | 0.25 |
| Stochastic Oscillator | 37.50 | 81.47 |
Price Performance
Historical ComparisonAbout ADAMM Adamas Trust Inc. 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.